Exploring CNN potential in discriminating benign and malignant calcifications in conventional and dual-energy FFDM:

Andrey Makeev1, Gabriela Rodal1, Bahaa Ghammraoui1

  • 1Food and Drug Administration, Silver Spring, Maryland, United States.